Our Community

Members

American Cancer Society

Arkansas Bioinformatics Consortium

Association for Molecular Pathology

Bio-Rad Laboratories

Breast Cancer Research Foundation

Bristol Myers Squibb

Center for Translational Data Science
at the University of Chicago

Center for Genetic Medicine Research
at Children’s National Medical Center

Ceres Nanosciences

Cordance Medical

Delfi Diagnostics

Eli Lilly and Company

OncoRNALab Ghent University

Open Commons Consortium

Personal Genome Diagnostics

Prevent Cancer Foundation

The Prostate Cancer Clinical Trials Consortium

Prostate Cancer Foundation

Quest Diagnostics

Sysmex Inostics, Inc.

Thermo Fisher Scientific

University of Southern California

U.S. Department of Veterans Affairs

Windber Research Institute

Collaborators

Center for Medical Technology Policy

College of American Pathologist / Arizona State University

U.S. Department of Defense

U.S. Food & Drug Administration

External Data Contributors

University of California, Los Angeles

Henry Ford Health System

“Organizations involved in the development of diagnostic technologies must keep pace with breakthroughs in targeted cancer treatment being developed by the biopharmaceutical industry. The unique collaboration led by BLOODPAC allows just that, enabling innovators of liquid biopsy assays to accelerate their work and develop tools needed to accurately profile cancers and inform treatment decisions.”

— Anne-Marie Martin, Senior Vice President, Global Head, Experimental Medicine Unit, GSK